We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

22 hedge funds and large institutions have $1.63M invested in Edesa Biotech in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.21% less ownership

Funds ownership: 1.6% → 1.39% (-0.21%)

15% less funds holding

Funds holding: 26 → 22 (-4)

21% less capital invested

Capital invested by funds: $2.05M → $1.63M (-$423K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CIBC World Market
CIBC World Market
Ontario, Canada
+$51.9K
2
CM
CM Management
Florida
+$47.5K
3
Wells Fargo
Wells Fargo
California
+$7

Top Sellers

Rank Fund Capital Flow
1
LCM
Lynwood Capital Management
Ontario, Canada
-$262K
2
Renaissance Technologies
Renaissance Technologies
New York
-$16K
3
Two Sigma Investments
Two Sigma Investments
New York
-$14.4K
4
SS
Simplicity Solutions
Minnesota
-$9.12K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$6.39K
Name Holding Trade Value Shares
Change 		Change in
Stake
VCIM
1
Velan Capital Investment Management
Georgia
$1.04M – – –
CM
2
CM Management
Florida
$304K +$47.5K +7,142 +15%
Vanguard Group
3
Vanguard Group
Pennsylvania
$89.9K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$69.4K – – –
CIBC World Market
5
CIBC World Market
Ontario, Canada
$44K +$51.9K +7,804 New
State Street
6
State Street
Massachusetts
$35.2K – – –
Northern Trust
7
Northern Trust
Illinois
$18.3K – – –
Two Sigma Investments
8
Two Sigma Investments
New York
$9.38K -$14.4K -2,162 -57%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$8.84K -$6.39K -962 -38%
TRCT
10
Tower Research Capital (TRC)
New York
$6.91K -$1.06K -160 -12%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$1K – – –
TWC
12
TD Waterhouse Canada
Ontario, Canada
$800 – – –
Fifth Third Bancorp
13
Fifth Third Bancorp
Ohio
$568 – – –
BlackRock
14
BlackRock
New York
$420 – – –
GRP
15
Global Retirement Partners
California
$142 – – –
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
$109 – – –
Wells Fargo
17
Wells Fargo
California
$95 +$7 +1 +6%
National Bank of Canada
18
National Bank of Canada
Quebec, Canada
$45 – – –
UBS Group
19
UBS Group
Switzerland
$27 -$5.38K -810 -99%
AWM
20
AllSquare Wealth Management
New York
$9 – – –
Credit Agricole
21
Credit Agricole
France
$7 – – –
Osaic Holdings
22
Osaic Holdings
Arizona
$6 – – –
LCM
23
Lynwood Capital Management
Ontario, Canada
– -$262K -41,071 Closed
Renaissance Technologies
24
Renaissance Technologies
New York
– -$16K -2,500 Closed
SS
25
Simplicity Solutions
Minnesota
– -$9.12K -1,429 Closed
1
2

EDSA Hedge Fund Activity: Q2 2023 in Review

22 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2023, worth a combined $1.63M — down 21% from $2.05M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of EDSA and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was CIBC World Market, opening a new position worth an estimated $51.9K. The largest seller was Lynwood Capital Management, exiting entirely with an estimated $262K sold.

  • 22 institutional investors held Edesa Biotech (EDSA) as of Q2 2023, down from 26 in Q1 2023.
  • Funds reported $1.63M of Edesa Biotech stock for Q2 2023, down 21% quarter-over-quarter.
  • 1 fund opened new Edesa Biotech positions in Q2 2023 and 5 closed out, a net change of -4 holders.
  • The largest Edesa Biotech buyer in Q2 2023 was CIBC World Market, an estimated $51.9K added.
  • The largest Edesa Biotech seller in Q2 2023 was Lynwood Capital Management, an estimated $262K sold.

Based on aggregated 13F filings for Q2 2023.